Timber Pharmaceuticals (AMEX:TMBR) reported quarterly losses of $(0.05) per share. This is unchanged from the same period last year. The company reported $83.18 thousand in sales this quarter. This is a 104.20 percent increase over sales of $40.73 thousand the same period last year.
Tilray Medical Relaunches Cannabis Oral Solution Across Ireland
Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today
